Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ehime Prefectural Niihama Hospital, Niihama, Japan.
Int J Cardiol. 2019 Sep 15;291:13-18. doi: 10.1016/j.ijcard.2019.02.038. Epub 2019 Feb 20.
Possible ethnic differences in clinical characteristics and long-term prognosis of contemporary patients with vasospastic angina (VSA) remain to be elucidated.
The Japanese Coronary Spasm Association (JCSA) conducted an international, prospective, and multicenter registry study for VSA patients. A total of 1457 VSA patients (Japanese/Caucasians, 1339/118) were enrolled based on the same diagnostic criteria. Compared with Caucasian patients, Japanese patients were characterized by higher proportions of males (68 vs. 51%) and smoking history (60 vs. 49%). Japanese patients more often had angina especially during the night and early morning hours, compared with Caucasians. Ninety-five percent of Japanese and 84% of Caucasian patients underwent pharmacological provocation test. Importantly, no significant differences in the patterns of coronary spasm were apparent, with diffuse spasm most frequently noted in both ethnicities. The prescription rate of calcium-channel blockers was higher in Japanese (96 vs. 86%), whereas the uses of nitrates (46 vs. 59%), statins (43 vs. 65%), renin-angiotensin-system inhibitors (27 vs. 51%), and β-blockers (10 vs. 24%) were more common in Caucasian patients. Survival rate free from major adverse cardiac events (MACE) was slightly but significantly higher in Japanese than in Caucasians (86.7 vs. 76.6% at 5 years, P < 0.001). Notably, multivariable analysis revealed that the JCSA risk score correlated with MACE rates not only in Japanese but also in Caucasian patients.
These results indicate that there are ethnic differences in clinical profiles and long-term prognosis of contemporary VSA patients.
目前,关于血管痉挛性心绞痛(VSA)患者的临床特征和长期预后是否存在种族差异仍有待阐明。
日本冠状动脉痉挛协会(JCSA)针对 VSA 患者开展了一项国际性、前瞻性、多中心注册研究。根据相同的诊断标准,共纳入 1457 例 VSA 患者(日本人/白种人,1339/118)。与白种人患者相比,日本人患者中男性(68%比 51%)和有吸烟史的患者(60%比 49%)比例更高。与白种人相比,日本人更常出现心绞痛,尤其是在夜间和清晨。95%的日本人患者和 84%的白种人患者接受了药物激发试验。重要的是,两种族人群的冠状动脉痉挛模式并无显著差异,弥漫性痉挛在两种族人群中均最为常见。钙通道阻滞剂的处方率在日本人中较高(96%比 86%),而硝酸盐(46%比 59%)、他汀类药物(43%比 65%)、肾素-血管紧张素系统抑制剂(27%比 51%)和β受体阻滞剂(10%比 24%)的使用率在白种人中更高。无重大不良心脏事件(MACE)生存率在日本人中略高于白种人(5 年时分别为 86.7%和 76.6%,P<0.001)。值得注意的是,多变量分析显示,JCSA 风险评分不仅与日本人患者,而且与白种人患者的 MACE 发生率相关。
这些结果表明,当代 VSA 患者的临床特征和长期预后存在种族差异。